¤¤µØ¥Á°ê95¦~3¤ë15¤é½Ã¸pÂå¦r²Ä0950207650¸¹¥Oµo¥¬
²Ä¤@±ø¡@¥»¼Ð·Ç¨Ì¦å²G»s¾¯±ø¨Ò²Ä¤Q¥|±ø²Ä¤G¶µ³W©wq©w¤§¡C
²Ä¤G±ø ®½¦åªÌ¶·²Å¦X¤U¦C±ø¥ó¡A©l±o®½¦å¡G
¤@¡B¦~ÄÖ¡G
(¤@)¤Q¤C·³¥H¤W¡A¤»¤Q¤·³¥H¤U¡A¤@¯ë°·±d±¡ªp¨}¦n¡C
(¤G)¥¼º¡¤Q¤C·³ªÌ¡AÀ³µøÅé¯àª¬ªp¡A¨Ã¸gªk©w¥N²z¤H¤§¦P·N¡A©l±o®½¦å¡C
(¤T)¹O¤»¤Q¤·³ªÌ¡A°£À³°·±d±¡ªp¨}¦n¥~¡A¨ÃÀ³¨ú±oÂå®v¤§¦P·N¡A©l±o®½¦å¡C
¤G¡BÅé«¡G
(¤@)¤k©ÊÀ³¥|¤Q¤¤½¤ç¥H¤W¡A¨k©ÊÀ³¤¤Q¤½¤ç¥H¤W¡C
(¤G)®½¤ÀÂ÷³N¦å¤pªO¡B¤ÀÂ÷³N¥Õ¦å²y¤Î¤ÀÂ÷³N¦å¼ßªÌ¡AÀ³¤¤Q¤½¤ç¥H¤W¡C
¤T¡BÅé·Å¡G¤f·Å¤£¶W¹LÄá¤ó¤T¤C¡D¤«×¡C
¥|¡B¦åÀ£¡G¦¬ÁYÀ£¤E¡³¡ã¤@¤»¡³²@¦Ì¨E¬W¡AµÎ±iÀ£¤¡³¡ã¤E¤²@¦Ì¨E¬W¡A¦p¨âªÌ¤§¶ZÂ÷§C©ó¤T¡³©Î°ª©ó¤E¡³²@¦Ì¨E¬W¡A¶·¸gÂå®v³\¥i¡C
¤¡B¦å²GÀˬd¡G
(¤@)¦å¬õ¯À¡G¨k©Ê¤Q¤T¤½§J%¥H¤W¡]¨Ï¥Î²¸»Ä»Éªk®É¦å²G¤ñ«¤@£»¡³¤¥|¡^¡C¤k©Ê¤Q¤G¤½§J%¥H¤W¡]¨Ï¥Î²¸»Ä»Éªk®É¦å²G¤ñ«¤@£»¡³¤¤G¡^¡C
(¤G)¦å¤pªO¡G®½¦å¤pªOªÌ¡A¨ä¦å¤pªO¼Æ¥ØÀ³¦b15×10,000/mm3¥H¤W¡C
(¤T)¥Õ¦å²y¡G®½¥Õ¦å²yªÌ¡A¨äµ´¹ïÁû²É²y¼Æ¥ØÀ³¦b3,000/mm3¥H¤W¡C
(¥|)¦å¼ßÁ`³J¥Õ¡G®½¦å¼ßªÌ¡AÀ³©óº¦¸®½¦åº[¨C¹j¥b¦~¥[Åç¦å¼ßÁ`³J¥Õ¶q¡A¨ä¦å¼ßÁ`³J¥ÕÀ³¦b6g/d1¥H¤W¡C
²Ä¤T±ø ®½¦åªÌ¨C¦¸¤§®½¦å¶q¤Î®½¦å¶¡¹j¦p¤U¡G
¤@¡B¨C¦¸®½¦å¥H¤G¤¡³²@¤É¬°ì«h¡A¦ýÅ髤»¡³¤½¤ç¥H¤WªÌ¡A¨C¦¸®½¦å±o¬°¤¡³¡³²@¤É¡C
¤G¡B¨C¦¸®½¦å¤G¤¡³²@¤ÉªÌ¡A¨ä®½¦å¶¡¹jÀ³¬°¤GÓ¤ë¥H¤W¡F¨C¦¸®½¦å¤¡³¡³²@¤ÉªÌ¡A¨ä®½¦å¶¡¹jÀ³¬°¤TÓ¤ë¥H¤W¡C¦ý¨k©Ê¦~®½¦å¶qÀ³¦b¤@¡B¤¡³¡³²@¤É¥H¤º¡F¤k©Ê¦~®½¦å¶qÀ³¦b¤@¡B¡³¡³¡³²@¤É¥H¤º¡C
¤T¡B®½¤ÀÂ÷³N¦å¤pªO¡B¤ÀÂ÷³N¥Õ¦å²y©Î¤ÀÂ÷³N¦å¼ßªÌ¡A¨C¦¸¤§¶¡¹j¬°¤G¬P´Á¥H¤W¡C
¥|¡B®½¤ÀÂ÷³N¦å¼ß¶q¨C¦¸¥H¤¡³¡³²@¤É¬°¡A¨ä¥þ¦~®½¦å¼ß¶q¤£±o¶W¹L¤Q¤G¤½¤É¡C
²Ä¥|±ø¡@®½¦åªÌ¦³¤U¦C±¡§Î¤§¤@ªÌ¡AÀ³¼È½w®½¦å¡G
¤@¡B°ü¤kÃh¥¥¤¤©Î²£«á¡]§t¬y²£«á¡^¤»Ó¤ë¥H¤ºªÌ¡C
¤G¡B¤j¤â³N¥¼º¡¤@¦~©Î¤@¦~¤º´¿±µ¨ü¿é¦åªÌ¡C
¤T¡B¥|¬P´Á¤º´¿±µºØ³Â¯l¡B¼w°ê³Â¯l¡B¸|¸¢ª¢¤Î¤p¨à³Â·ô¡]¤fªA¡^µ¥¬¡©Ê´î¬r¬Ì]ªÌ¡C
¥|¡B¤»Ó¤ë¤º´¿¿©±w¨xª¢©Î±K¤Á±µÄ²¨xª¢¯f±wªÌ¡C
¤¡B²{±w±ö¬r¡B¬¡°Ê©Êµ²®Ö¯f¡B¿}§¿¯f¡B¤ßŦ¯f¡B®ø¤Æ¹D¼ìºÅ¥X¦å¡B°ª¦åÀ£¡BµÇŦ¯f¡Bý³Ý¡B·P«_¡B«æ©Ê·P¬V¡B¶Ç¬V¯f¡B¹L±Ó¯f¯gªÌ¡C
¤»¡B¦ÛºÄ¯e¬Ì°Ï¦^°ê¤@¦~¤º©Î´¿¦b¤T¦~¤º¿©±wºÄ¯eªÌ¡C
¤C¡B´¿¦b¤C¤Q¤G¤p®É¤º©Þ¤úªÌ¡C
¤K¡B´¿¦b¤¤Ñ¤ºªA¥Î§tAspirinÃþÃĪ«©Î¨ä¥L¥i§í¨î¦å¤pªO¥\¯à¤§ÃĪ«ªÌ¡A¤£±o®½¦å¤pªO¡C
¤E¡BB«¬¨xª¢ªí±§ÜìÀˬd§e¶§©Ê¤ÏÀ³ªÌ¡C
¤Q¡BC«¬¨xª¢¯f¬r§ÜÅéÀˬd§e¶§©Ê¤ÏÀ³ªÌ¡C
¤Q¤@¡B¥Á°ê¤»¤Q¤E¦~¦Ü¤K¤Q¤¦~¶¡´¿¦b^°ê¿é¦å©Î´¿¦Ü^°ê®È¹C©Î©~¯d®É¶¡¦Xp¶W¹L¤TÓ¤ëªÌ¡A©Î¥Á°ê¤»¤Q¤E¦~¥H«á´¿©ó¼Ú¬w®È¹C©Î©~¯d®É¶¡¦Xp¶W¹L¤¦~ªÌ¡C
¤Q¤G¡B¸g³q³ø¬°ÄY««æ©Ê©I§l¹D¯gÔ¸sºÃ¦ü©Î¥i¯à¯f¨Ò¡A©óªvÀø²¬Â¡«á¡A¥¼¹O¤TӤ뤺ªÌ¡C
¤Q¤T¡B´¿»PÄY««æ©Ê©I§l¹D¯gÔ¸sºÃ¦ü©Î¥i¯à¯f¨Ò±K¤Á±µÄ²¡A©ó³Ì«á±µÄ²¤é°_¤@Ӥ뤺ªÌ¡C
¤Q¥|¡B¦Û¦³¦a°Ï©Ê¶Ç¼½ÄY««æ©Ê©I§l¹D¯gÔ¸s¤§¦a°Ï¦^°ê«á¤@Ӥ뤺ªÌ¡C
¤Q¤¡B¦Û¦è¥§Ã¹¯f¬r¬y¦æ°ÏÂ÷¹Ò¤é°_¤@Ӥ뤺ªÌ¡C
¤Q¤»¡BÃhºÃ¦Û¤v·P¬V·R´þ¯f¬rªÌ©Î¤G¦~¤º´¿»P¥i¯à·P¬V·R´þ¯f¬rªÌµo¥Í©Ê¦æ¬°ªÌ¡C
¤Q¤C¡B¤@¦~¤º´¿±q¨Æ¦MÀI©Ê¦æ¬°©Î´¿¿©±w©Ê¯f¡]±ö¬r¡B²O¯f¡B©Ü¦çµß¡B¥Í´Þ¾¹¯p¯l¡B³n©Ê¤U¯i¡B¦y«¬Àã¬Ðµ¥¡^ªÌ¡C
¤Q¤K¡B¤@¦~¤º´¿¨ë«CªÌ¡C
²Ä¤±ø¡@®½¦åªÌ¦³¤U¦C±¡§Î¤§¤@ªÌ¡A¥Ã¤£±o®½¦å¡G
¤@¡B´¿±w´c©Ê¸~½F¡B¥Õ¦å¯f©Î¨ä¥L¸gÂå®v»{¬°¥Ã¤[¤£±o®½¦åªÌ¡C
¤G¡B´¿¦³¥X¦å¤£¤î¡B©âµj©Î©ü°g¤§¯f¥vªÌ¡C
¤T¡B´¿¦³§l¬r©ÎºC©Ê°sºë¤¤¬rªÌ¡C
¥|¡BÀR¯ßª`®gÃĪ«¦¨Å}ªÌ¡B¨k©Ê¶¡©Ê¦æ¬°ªÌ¤Îªø´Á¨Ï¥Î¦å²G»s¾¯ªÌ¡C
¤¡B´¿¬°AIDS±wªÌ¡C
¤»¡B·R´þ¯f¬r²Ä¤@«¬¤Î²Ä¤G«¬¡]HIV-I / HIV-II¡^§ÜÅéÀˬd¸g½T»{§e¶§©Ê¤ÏÀ³ªÌ¡C
¤C¡B¤HÃþ¶ÝT²O¤Ú²y¯f¬r²Ä¤@«¬¡]HTLV-I¡^§ÜÅéÀˬd¸g½T»{§e¶§©Ê¤ÏÀ³ªÌ¡C
¤K¡B´¿¿©±w®w¸ë¤ó¯fªÌ¡]CJD¡^¡B´¿ª`®g¤HÃþ¸£¤U««Åé¥Íªø²üº¸»XªÌ¡B´¿ª`®g¤HÃþ¸£¤U««Åé¿Ë¥Í´Þ¸¢¯À¡]human pituitary gonadotropins¡^ªÌ¡B´¿ª`®g¤û¯Ø®q¯Àµ¥¥Íª«»s¾¯ªÌ¡B´¿±µ¨üµw¸£½¤²¾´ÓªÌ©Î®a±Ú¤¤¦³®w¸ë¤ó¯f¡]CJD¡^±wªÌ¡C
¤E¡B´¿±q¨Æ©Ê¤u§@ªÌ¡C
²Ä¤»±ø ®½¦å¾÷ºc¹ï®½¦åªÌ¹ê¬I°·±d¿zÀˤ§¶µ¥Ø¦pªþªí¡C
²Ä¤C±ø ¥»¼Ð·Ç¦Ûµo¥¬¤é¬I¦æ¡C
¡·ªþªí¡G®½¦åªÌ°·±d¿zÀ˶µ¥Ø
|
¤@¡BÅé«¡G¤k©ÊÀ³45¤½¤ç¥H¤W¡A¨k©ÊÀ³50¤½¤ç¥H¤W¡C
¤G¡BÅé·Å¡G¤f·Å¤£¶W¹LÄá¤ó37.5«×¡C
¤T¡B¦åÀ£¡G¦¬ÁYÀ£90~160²@¦Ì¨E¬W¡AµÎ±iÀ£50~95²@¦Ì¨E¬W¡A¦p¨âªÌ¤§¶ZÂ÷§C©ó30©Î°ª©ó90²@¦Ì¨E¬W¡A¶·¸gÂå®v³\¥i¡C
¥|¡B¦å²GÀˬd
¡]¤@¡^¦å¬õ¯À¡G¨k©Ê13¤½§J%¥H¤W¡]¨Ï¥Î²¸»Ä»Éªk®É¦å²G¤ñ« 1.054¡^¡C
¤k©Ê12¤½§J%¥H¤W¡]¨Ï¥Î²¸»Ä»Éªk®É¦å²G¤ñ«1.052¡^¡C
¡]¤G¡^¦å¤pªO¡G®½¦å¤pªOªÌ¡A¨ä¦å¤pªO¼Æ¥ØÀ³¦b15×10,000/mm3¥H¤W¡C
¡]¤T¡^¥Õ¦å²y¡G®½¥Õ¦å²yªÌ¡A¨äµ´¹ïÁû²É²y¼Æ¥ØÀ³¦b3,000/mm3¥H¤W¡C
¡]¥|¡^¦å¼ßÁ`³J¥Õ¡G®½¦å¼ßªÌ¡AÀ³©óº¦¸®½¦åº[¨C¹j¥b¦~¥[Åç¦å¼ßÁ`³J¥Õ¶q¡A¨ä¦å¼ßÁ`³J¥ÕÀ³¦b6g/d1¥H¤W¡C
¤¡BABO¦å«¬ÀËÅç¡C
¤»¡BRh ¦å«¬ÀËÅç¡C
¤C¡B¬õ¦å²y²§Åé§ÜÅé¿zÀË¡C
¤K¡B¦å²MÂàÓi酶ÀËÅç (ALT)¡C
¤E¡B±ö¬r¦å²MÀËÅç (STS)¡C
¤Q¡BB«¬¨xª¢¯f¬rªí±§ÜìÀËÅç (HBsAg)¡C
¤Q¤@¡B¤HÃþ§K¬Ì¯Ê¥F¯f¬r²Ä¤@«¬¡B²Ä¤G«¬§ÜÅéÀËÅç (Anti- HIV-1/2)¡C
¤Q¤G¡BC«¬¨xª¢¯f¬r§ÜÅéÀËÅç (Anti-HCV)¡C
¤Q¤T¡B¤HÃþ¶ÝT²O¤Ú²y¯f¬r§ÜÅéÀËÅç (Anti-HTLV-I/II)¡C
|